Pierre Heimendinger
Corporate Officer/Principal at TXCELL
Profile
Pierre Heimendinger is currently the Vice President-Process Development at Sangamo Therapeutics France SAS.
He holds a doctorate degree from Université Paris Diderot-Paris 7.
Pierre Heimendinger active positions
| Companies | Position | Start |
|---|---|---|
| TXCELL | Corporate Officer/Principal | - |
Training of Pierre Heimendinger
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
| Université Paris Diderot-Paris 7 | Consumer Services |
- Stock Market
- Insiders
- Pierre Heimendinger
